BridgeBio Pharma
Pharmaceuticals
BridgeBio Pharma valuation and funding history | Last updated: January 23, 2019 | 2 funding rounds
Current Valuation
N/A
As of January 23, 2019
Total Funding Raised
N/A
Across 2 rounds
Last Round
Later Stage VC (Series D)
$299.2M
Last Funding
Jan 2019
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 23, 2019 | Later Stage VC (Series D) | $299.2M | N/A | - |
| April 10, 2018 | Later Stage VC (Series C) | $135.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
BridgeBio Pharma is currently valued at N/A as of January 23, 2019.
What is BridgeBio Pharma Worth in 2026?
BridgeBio Pharma is a leading private company in the Pharmaceuticals sector. Track BridgeBio Pharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How BridgeBio Pharma Valuation is Determined
Private company valuations like BridgeBio Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.